UBS Maintains a 'Buy' on RenaissanceRe Holdings (RNR); Improved
Get Alerts RNR Hot Sheet
Price: $235.40 --0%
Rating Summary:
8 Buy, 10 Hold, 3 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 39
Rating Summary:
8 Buy, 10 Hold, 3 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 39
Join SI Premium – FREE
UBS maintains a 'Buy' on RenaissanceRe Holdings (NYSE: RNR) price target raised from $83 to $88.
Analyst, Brian Meredith, said, "1Q12 EPS of $2.98, above UBSe of $2.35 and consensus $2.48...Top line growth benefits from pricing and growth at Lloyds...Strong alternative investments, but weather&risk unit posts more losses...We are increasing our 2012E EPS to $9.00 (prior $8.22), primarily reflecting the 1Q12 earnings upside surprise."
For an analyst ratings summary and ratings history on RenaissanceRe Holdings click here. For more ratings news on RenaissanceRe Holdings click here.
Shares of RenaissanceRe Holdings closed at $77.97 yesterday.
Analyst, Brian Meredith, said, "1Q12 EPS of $2.98, above UBSe of $2.35 and consensus $2.48...Top line growth benefits from pricing and growth at Lloyds...Strong alternative investments, but weather&risk unit posts more losses...We are increasing our 2012E EPS to $9.00 (prior $8.22), primarily reflecting the 1Q12 earnings upside surprise."
For an analyst ratings summary and ratings history on RenaissanceRe Holdings click here. For more ratings news on RenaissanceRe Holdings click here.
Shares of RenaissanceRe Holdings closed at $77.97 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Adverum Biotechnologies (ADVM) PT Lowered to $2 at RBC Capital Following Earnings
- Micron Technology (MU) PT Raised to $120 at UBS, 'see results biased to the high-end of guidance'
- Caribou Biosciences Inc. (CRBU) PT Raised to $24 at H.C. Wainwright on better results and estimates
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBS, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!